Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-dose versus standard-dose taxane + thiotepa chemotherapy for metastatic breast cancer
ChiCTR-TRC-09000573Phase 4Completed
- Sponsor
- Peking University Cancer Hospital & Institute
- Start
- Jan 2004
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of docetaxel, paclitaxel and thiotepa in breast cancer (2 arms), sponsored by Peking University Cancer Hospital & Institute. Primary endpoint: Progression-free survival. Started Jan 2004; status: completed.
02
Drugs
docetaxelpaclitaxelthiotepa
03
Conditions
breast cancer
Beyond the preview
Go deeper on ChiCTR-TRC-09000573.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-09000573.